Nureca Limited IPO: Date, Review, Analysis, Price, Financial Performance & Valuation

Manish Kothari
20 Likes | 848 days ago



isVerifiedExpertAuthor is a Zfunds Verified Expert
Manish Kothari


Nureca Limited, incorporated in 2016, is a B2C company that is engaged in home healthcare & wellness products. Its products offer quality, functionality, durability, usability, and innovative designs. Nureca limited enables their customers with the tools which help to monitor the chronic alignments or other diseases to improve the lifestyle of the user. The company believes in innovation and catering new & innovative products for the ever-growing needs in the home healthcare sector.

It is a digital-first company that sells its products through online channel partners which include e-commerce players, retailers, and distributors. It also sells its products through its own website drtrust.in.

Nureca limited has a diversified portfolio of products that primarily caters to the home healthcare sector. Its product portfolio includes chronic device products, orthopedic products, mother & child products, nutrition supplements, and lifestyle products.

The company has shown a growth of 60.50% and 2.73% in their revenue and profit for the FY2020 over the FY2019. The Companie’s net profit has shown growth with a CAGR of 43.35% during the fiscal year 2018 to 2020.

The promoter of the company is Mr. Saurabh Goyal.

Strengths of the company

  • The company has a diversified portfolio of products catering to the needs of different customers across the industry of home healthcare.
  • The company is a well-recognized brand having a targeted marketing strategy.
  • The company has a wide sales and diversified distribution network across India.
  • The promoters of the company are well-experienced and have a strong management team with domain knowledge.
  • The company has a strong track record with robust financial performance.

Purpose of the IPO

  • To meet the incremental working capital requirement of the company.
  • For general corporate purposes.

Financial Performance of the company

 For the period ended 30th June 2020FY 2020FY 2019FY 2018
Total Revenue30.3899.4861.9820.06
Total Expenses17.6890.8753.1415.74
Profit after tax9.446.396.223.11
Total Assets42.5833.8823.517.01

*All the values are in crores and as per DRHP.

Valuation of the company

 For the period  ended 30th June 2020FY 2020FY 2019FY 2018
Basic Earnings per Share (EPS)13.509.148.894.45
Diluted Earnings per Share (EPS)13.509.148.894.45
Return on Net Worth (%)38.74%42.82%78.36%180.93%
Net Assets Value per Equity Share243.8614,934.007,945.001,720.00

*as per DRHP

Nureca Limited IPO DRHP

IPO details

Face Value₹10 Per Equity Share
Market Lot35 Shares
Minimum Order Quantity35 Shares
Price Band₹396 - ₹400 Per Equity Share
Issue typeBook Built Issue IPO
Issue Size₹100  Crores
Fresh Issue₹100 Crores
Offer for Sale-
Listing BSE, NSE

*Employee discount ₹20 per share.

Important IPO dates

Open Date15th February 2021
Close Date17th February 2021
Allotment Date23rd February 2021
Initiation of Refunds24th February 2021
The credit of shares to Demat Account25th February 2021
Listing Date26th February 2021

Allocation Quota

Qualified Institutional Buyers (QIBs)75%
Non- Institutional Buyers (NIIs)15%
Retail Investors10%

Check your Nureca LTD IPO allotment status here:

Linkline IPO allotment Status: Click here

BSE IPO Allotment Status: Click here

NSE IPO Allotment Status: Click here

Get Investment Advice from India's Top Experts